Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Pfizer (NY: PFE)
42.52 USD  -0.59 (-1.38%)
Streaming Delayed Price  /  Updated: 2:42 PM EST, Dec 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 16,818,490
Open 43.47
Bid (Size) 42.50 (28)
Ask (Size) 42.51 (20)
Prev. Close 43.11
Today's Range 42.38 - 43.50
52wk Range 33.20 - 46.47
Shares Outstanding 5,849,571,048
Dividend Yield 3.20%
Performance
YTD
+16.67%
+16.67%
1 Month
-3.77%
-3.77%
3 Month
-1.15%
-1.15%
6 Month
+17.57%
+17.57%
1 Year
+14.50%
+14.50%
Top News
More News
Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 29, 2019. The purpose of the call... Read More
from Business Wire News Releases
Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies
Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive up to $505 million in potential research, development and sales milestone payments Read More
from PR Newswire
More News
Read More
Pfizer Declares First-Quarter 2019 Dividend
from Business Wire News Releases
Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab)
from Business Wire News Releases
Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
from Business Wire News Releases
Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved
category VRTX , AERI , RIGL , and 19 more.
from Benzinga
Nicox teams up with Chinese firm to develop and sell glaucoma drug
category companyNews
from Reuters: Company News
3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think
category Market News , PFE
from Motley Fool
FDA approves Celltrion's biosimilar to Roche's Herceptin
category companyNews
from Reuters: Company News
Thirteen Companies Boosting Distributions For Long-Term Shareholders
category Stocks / Equities
from Blogs - TalkMarkets
Pfizer's cut-price version of Avastin wins EU panel greenlight
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X